National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
 
 
Results: 1 -10 of 48         results per page
View Search Criteria | Help With Results
Title 
Phase sort descending
Protocol IDs 
 
Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation

   
Phase IV

   
hsc 031192
ind 70268, NCT00285272

 
 
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors

   
Phase IV

   
2006-00055-18
NCT00415103

 
 
Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients

   
Phase IV

   
UMCN-AKF 07.02
EudraCTnr 2007-003347-73, NCT00588835

 
 
Radical Prostatectomy and Perioperative Fluid Therapy

   
Phase IV

   
RCT_PROST_ORTO
NCT00771966

 
 
Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer

   
Phase III, Phase II

   
URCC-U1902
URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742

 
 
Nexium Study To Suppress Nausea During Chemotherapy

   
Phase III

   
H-16348
Nexium Study, NCT00206440

 
 
Phase 3 Study of Acupression's Bracelets in Nausea and Vomiting Induced by FEC100 Chemotherapy's Sort.

   
Phase III

   
05 DIVE 05
NCT00268125

 
 
Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/Vomiting

   
Phase III

   
9561702041
NCT00360841

 
 
Placebo-Controlled Evaluation of Cocculine® Efficacy in the Management of Nausea After Chemotherapy in Breast Cancer.

   
Phase III

   
COCCULINE
ET2005-028, NCT00409071

 
 
Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Women Undergoing Chemotherapy for Breast Cancer

   
Phase III

   
URCC-04-02
URCC 0402, URCC-U1105, U1105, NCT00475085

 
      1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov